By activating three receptors, it helps control blood sugar and supports weight loss by: Boosting insulin release and sensitivity Reducing glucagon to prevent excess glucose production Slowing down digestion (gastric emptying) and making you feel fuller (increased satiety levels), which helps you eat less (reduced calorie intake) Eli Lilly finished their phase II trials for retatrutide and shared the results in June 2023
In the 36-week study, patients treated with rezpegaldesleukin showed more than double the improvement in hair growth compared with placebo
Because peptide scheduling can change between publication and purchase, laboratory buyers should confirm the current position directly with the MHRA and Home Office before placing an order, particularly if your institution requires written regulatory sign-off for incoming research materials
Because theyre not regulated by the FDA, check that the peptide powder has been tested to be pure by an independent laboratory such as NSF or USP
At the time of writing, retatrutide has not received marketing authorisation from the MHRA or the EMA, and therefore does not have an approved Summary of Product Characteristics (SmPC) or Patient Information Leaflet (PIL) in the UK
